Delivery Order SPE2DB22D3011-SPE2DB25FQ1FP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,195.90 to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with performance completion scheduled for June 4, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $1,569.12 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 6, 2025, with completion targeted for August 7, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,594.26 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,451.13 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) on July 23, 2025, with completion scheduled for July 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,097.53 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed price contract type. The award, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,832.00 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone otic suspension in 7.5 mL units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 19, 2025. The award was issued on August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,569.12 firm fixed-price delivery order on August 28, 2025, for Ciprofloxacin-Dexamethasone otic suspension in 7.5ml units, with completion scheduled for August 29, 2025. This delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,452.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone otic suspension (7.5 mL), with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999 and extending through December 2026. The prime IDC serves as a...
- The Defense Logistics Agency awarded a $1,670.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5 mL quantities. This is an unset-aside, competitively awarded contract with an ultimate completion date of July 22, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.06 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with an ultimate completion date of June 20, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ1FPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,135.35 to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Ciprofloxacin-Dexamethasone otic suspension (7.5ML). This non-competitive, firm fixed-price delivery order is scheduled for completion by June 13, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements, typical of the company's extensive engagement with the Defense Logistics Agency's medical supply chain. This delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle valued through December 2026 that authorizes the company to supply pharmaceutical products and medical commodities globally to support military healthcare programs. As a child order under this comprehensive IDC, the award leverages the established relationship and pricing structures negotiated in the larger vehicle, enabling rapid fulfillment of specific medication requirements for Defense Health Agency operations and other federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains its position as a critical vendor for federal medical procurement through its demonstrated capability to meet competitive award requirements across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/12/25 |